B+
Bull case
25%
Probability
Target price
$450.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
HUM
HumanaBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 operating metrics were constructive, adjusted guidance was maintained, MA membership growth remains strong, CenterWell added 130,900 patients year to date, and the Illinois Medicaid contract supports longer-term growth. [#SEC-8K-2026-07-29]
Posture
Constructive
Lead driver
Sentiment
What changed
3 setup hits (3d) with net bullish as of 2026-09-09.
What can break
FY2026 GAAP EPS guidance was cut despite maintained adjusted guidance. [#SEC-8K-2026-07-29]
Momentum
79
Value
60
Sentiment
63
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $410.21 · Bull $450.00 · Bear $320.00Analysis 2026-08-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $420.54
Why
Momentum79 · Δ7d +10.4
Value60 · Δ7d -0.0
Sentiment63 · Δ7d +3.5
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 3 setup hits (3d) with net bullish as of 2026-09-09.
- • Sentiment remains the lead driver in the composite, 7D delta +3.5.
Contradictions & invalidation
- • FY2026 GAAP EPS guidance was cut despite maintained adjusted guidance. [#SEC-8K-2026-07-29]
- • Medical and pharmacy cost trends remain elevated, with stored earnings context indicating 7%–8% all-in 2026 trend and modestly higher drug trend expected for 2027. [#PR-EARNINGS-2026-07-30]
- • GAAP FY2026 EPS guidance was reduced to at least $6.52 from at least $8.36 while adjusted guidance held at at least $9.00.
Catalyst clock
2026-07-29
Q2 2026 results reaffirm adjusted outlook
Lead driver: Sentiment · See AI snapshot
Momentum
79
9% active weight
Current posture
7d trendImproving
Δ7d
+10.4
Δ21d
+5.7
Value
60
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+1.4
Sentiment
63
62% active weight
Current posture
7d trendImproving
Δ7d
+3.5
Δ21d
-4.9
Why this grade
Composite grade B. Momentum 79.1 / Value 60.4 / Sentiment 62.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$410.21
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$320.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$46.15B
Beta
0.44
Shares Out
120.08M
P/E (TTM)
25.8
P/S (TTM)
0.26
P/FCF (TTM)
29.67
Rev YoY
+26.2%
EPS YoY
+26.9%
Gross Margin
+14.0%
Op Margin
+1.9%
Net Debt
$8.74B
Current Ratio
1.74
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data